// App-Quantinova.ai

P340 : Risankizumab in Crohn's disease: Real World Experience from a Pre-Approval Access Program

Researchers

Presenter

  • Dawson, P

Principal Investigators

  • Sharma, E

  • Dart, R.J

  • Lim, S

  • Anderson, S.H

  • Ray, S

  • Mawdsley, J

  • Irving, P.M

  • Samaan, M.A

Medical Centers

  • Guy’s and St Thomas’ NHS Foundation Trust, Department of Rheumatology, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • C reactive protein

Drug/Treatment

  • Risankizumab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved